High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10480-10488

  Zink, M Christine ^a,b   Suryanarayana, Kalachar ^c   Mankowski, Joseph L ^a   Shen, Anding ^a   Piatak Jr , Michael ^c   Spelman, Jeffrey P ^a   Carter, Darryl L ^a   Adams, Robert J ^a   Lifson, Jeffrey D ^c   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CONTROLLED STUDY; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS; VIRUS LOAD; VIRUS REPLICATION;

EID: 0032708943     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10480-10488.1999     Document Type: Article

References (37)

1. Amedee, A. M., N. Lacour, J. L. Gierman, L. N. Martin, J. E. Clements, R. Bohn, R. M. Harrison, and M. Murphey-Corb. 1995. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J. Virol. 69:7982-7990.
2. Anderson, M. G., D. Hauer, D. P. Sharma, S. V. Joag, O. Narayan, M. C. Zink, and J. E. Clements. 1993. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 195:616-626.
3. Baskin, G. B., M. Murphey-Corb, L. N. Martin, K. F. Soike, F.-S. Hu, and D. Kuebler. 1991. Lentivirus-induced pulmonary lesions in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet. Pathol. 28:506-513.
4. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
5. Brew, B. J., L. Pemberton, P. Cunningham, and M. G. Law. 1997. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 175:963-966.
6. Budka, H. 1991. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:163-175.
7. Cinque, P., L. Vago, D. Ceresa, F. Mainini, M. R. Terreni, A. Vagani, W. Torri, S. Bossolasco, and A. Lazzarin. 1998. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 12:389-394.
8. Clements, J. E. Personal communication.
9. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, et al. 1995. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:2737-2744.
10. Dal Pan, G. J., H. Farzadegan, O. Selnes, D. R. Hoover, E. N. Miller, R. L. Skolasky, T. E. Nance-Sproson, and J. C. McArthur. 1998. Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia. J. Neurovirol. 4:95-99.
11. Di Stefano, M., L. Monno, J. R. Fiore, G. Buccoliero, A. Appice, L. M. Perulli, G. Pastore, and G. Angarano. 1998. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype. AIDS 12:737-743.
12. Eggers, C. C., J. van Lunzen, T. Buhk, and H. J. Stellbrink. 1999. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20:259-264.
13. Ellis, R. J., K. Ksia, S. A. Spector, J. A. Nelson, R. K. Heaton, M. R. Wallace, I. Abramson, J. H. Atkinson, I. Grant, J. A. McCutchan, and HIV Neurobehavioral Research Center Group. 1997. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann. Neurol. 42:679-688.
14. Ferrando, S., W. van Gorp, M. McElhiney, K. Goggin, M. Sewell, and J. Rabkin. 1998. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12:F65-F70.
15. Flaherty, M., D. A. Hauer, J. L. Mankowski, M. C. Zink, and J. E. Clements. 1997. Molecular and biological characterization of a neurovirulent molecular clone of SIV. J. Virol. 71:5790-5798.
16. Gendelman, H. E., J. Zheng, C. L. Coulter, A. Ghorpade, M. Che, M. Thylin, R. Rubocki, Y. Persidsky, F. Hahn, J. Reinhard, Jr., and S. Swindells. 1998. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178:1000-1007.
17. Glass, J. D., H. Fedor, S. L. Wesselingh, and J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:755-762.
18. Guyton, A. C. 1991. Textbook of medical physiology, 8th ed. W. B. Saunders, Philadelphia, Pa.
19. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
20. Johnson, R. T., J. D. Glass, J. C. McArthur, and B. W. Chesebro. 1996. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann. Neurol. 39:392-395.
21. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
22. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
23. Livak, K. J., S. J. Flood, J. Marmaro, W. Giusti, and K. Deetz. 1995. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 4:357-362.
24. Mankowski, J. L., M. A. Flaherty, J. P. Spelman, D. A. Hauer, P. J. Didier, A. Martin Amedee, M. Murphey-Corb, A. Munoz, J. E. Clements, and M. C. Zink. 1997. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J. Virol. 71:6055-6060.
25. McArthur, J. C., D. R. Hoover, H. Bacellar, E. N. Miller, B. A. Cohen, J. T. Becker, N. M. H. Graham, J. H. McArthur, O. A. Selnes, L. P. Jacobson, B. R. Visscher, M. Concha, and A. Saah. 1993. Dementia in AIDS patients: incidence and risk factors. Neurology 43:2245-2252.
26. McArthur, J. C., D. R. McClernon, M. F. Cronin, T. E. Nance-Sproson, A. J. Saah, M. St. Clair, and E. R. Lanier. 1997. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42:689-698.
27. Mellors, J. W, A. Muñoz, J. V. Giorgi, J. B. Margolick, C. J. Tassoni, P. Gupta, L. A. Kingsley, J. A. Todd, A. J. Saah, R Detels, J. P. Phair, and C. R. Rinaldo, Jr. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern Med. 126:946-954.
28. Murphey-Corb, M. Personal communication.
29. Murray, E. A., D. M. Rausch, J. Lendvay, L. R. Sharer, and L. E. Eiden. 1992. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 255:1246-1249.
30. Sharer, L. R., J. Michaels, M. Murphey-Corb, F.-S. Hu, D. J. Kuebler, L. N. Martin, and G. B. Baskin. 1991. Serial pathogenesis study of SIV brain infection. J. Med. Primatol. 20:211-217.
31. Sharma, D. P., M. C. Zink, M. Anderson, R. Adams, J. E. Clements, S. V. Joag, and O. Narayan. 1992. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J. Virol. 66:3550-3556.
32. Soontornniyomkij, V., J. A. Nieto-Rodriguez, A. J. Martinez, L. A. Kingsley, C. L. Achim, and C. A. Wiley. 1998. Brain HIV burden and length of survival after AIDS diagnosis. Clin. Neuropathol. 17:95-99.
33. Spencer, D. C., and R. W. Price. 1992. Human immunodeficiency virus and the central nervous system. Annu. Rev. Microbiol. 46:655-693.
34. Suryanarayana, K., T. A. Wiltrout, G. M. Vasquez, V. M. Hirsch, and J. D. Lifson. 1998. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res. Hum. Retroviruses 14:183-189.
35. Suryanarayana, K., et al. Unpublished data.
36. Wit, F. W., R van Leeuwen, G. J. Weverling, S. Jurriaans, K. Nauta, R. Steingrover, J. Schuljtemaker, X. Eyssen, D. Fortuin, M. Weeda, F. de Wolf, P. Reiss, S. A. Danner, and J. M. Lange. 1999. Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons. J. Infect. Dis. 179:790-798.
37. Zink, M. C., A. M. Amedee, J. L. Mankowski, L. Craig, P. Didier, D. L. Carter, A. Munoz, M. Murphey-Corb, and J. E. Clements. 1997. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am. J. Pathol. 151:793-803.